T14989 |
CMPD101
|
865608-11-3
|
99.01%
|
|
CMPD101 is a membrane-permeable small-molecule inhibitor of GRK2/3 (IC50: 18 nM and 5.4 nM). Which can be used for the study of heart failure. CMPD101 exhibits ...
|
T2482 |
AT13148
|
1056901-62-2
|
99%
|
|
AT13148 is an oral-active and ATP-competitive, multi-AGC kinase inhibitor for Akt1/2/3, p70S6K, PKA, and ROCKI/II.
|
T22037 |
AS 1892802
|
928320-12-1
|
98.9%
|
|
AS 1892802 is a potent and selective inhibitor of ROCK. AS 1892802 exibits IC50 values of 52nM, 57nM and 122 nM for human ROCK2, rat ROCK2 and human ROCK1, respe...
|
T1725 |
Y-27632 dihydrochloride
|
129830-38-2
|
98.80%
|
|
Y-27632 dihydrochloride (Y-27632 2HCl) is an orally potent, ATP-competitive inhibitor of ROCK-I and ROCK-II. Y-27632 dihydrochloride also inhibits isolation-indu...
|
T7764 |
CCG-222740
|
1922098-69-8
|
98.79%
|
|
CCG-222740 is an inhibitor of Rho/MRTF pathway
|
T4276L |
Hydroxyfasudil
|
105628-72-6
|
98.79%
|
|
Hydroxyfasudil (Hydroxy-Fasudil) is a ROCK inhibitor(IC50s of 0.73 and 0.72 μM for ROCK1 and ROCK2, respectively).
|
T2155 |
Thiazovivin
|
1226056-71-8
|
98.75%
|
|
Thiazovivin, a ROCK inhibitor (IC50: 0.5 μM), increases the survival rate of hESC.
|
T3518 |
GSK269962A
|
850664-21-0
|
98.63%
|
|
GSK269962A (GSK269962A HCl) is a selective ROCK(Rho-associated protein kinase) inhibitor with IC50 values of 1.6 and 4 nM for ROCK1 and ROCK2, respectively.
|
T4488 |
GSK-25
|
874119-56-9
|
98.59%
|
|
GSK-25 maintains good selectivity against a panel of 31 kinases, as well as RSK1 and p70S6K (RSK1 IC50 of 398 nM, p70S6K IC50 of 1000nM), and a dramatically impr...
|
T11402L |
GKI-1 HCl
|
T11402L
|
98.44%
|
|
GKI-1 HCl is a Greatwall (GWL) kinase inhibitor that inhibits hGWLFL and hGWL-KinDom.The inhibitory effect of GKI-1 HCl on ROCK1 is more significant.
|
T2633 |
GSK429286A
|
864082-47-3
|
98.42%
|
|
GSK429286A (RHO-15) is a specific inhibitor of ROCK1/2 (IC50: 14/63 nM).
|
T35328 |
H-1152 dihydrochloride
|
871543-07-6
|
98.42%
|
|
H-1152 dihydrochloride (H-1152 2HCl) is a specific inhibitor of Rho-associated protein kinase (ROCK) with an IC50 of 12 nM and a Ki of 1.6 nM. H-1152 dihydrochlo...
|
T15798 |
LX7101
|
1192189-69-7
|
98.42%
|
|
LX7101 is an effective inhibitor of LIMK and ROCK2 (IC50: 24, 1.6, and 10 nM for LIMK1, LIMK2, and ROCK2, respectively). It also inhibits PKA (IC50 <1 nM).
|
T38654 |
Cotosudil
|
1258833-31-6
|
98.41%
|
|
Cotosudil is a ROCK kinase inhibitor with antihypertensive activity and is used to treat or prevent diseases or conditions caused by cataracts, cardiovascular or...
|
T26078 |
Rhodblock 6
|
886625-06-5
|
98.27%
|
|
Rhodblock 6 is a Rho kinase (ROCK) inhibitor that inhibits the localization of phosphorylated MRLC (Myosin Regulatory Light Chain) and acts by specifically inhib...
|
T3513 |
GSK180736A
|
817194-38-0
|
98.16%
|
|
GSK180736A is an effective and selective GRK2 inhibitor (IC50: 0.77 μM) and >100-fold selectivity over other GRKs. It is a weak inhibitor of PKA (IC50: 30 μM), b...
|
T77609 |
WAY-656935
|
852902-81-9
|
98.1%
|
|
WAY-656935 inhibits ROCK.
|
T23308 |
SAR407899 hydrochloride
|
923262-96-8
|
98.01%
|
|
ATP-competitive ROCK inhibitor
|
T7301 |
BDP5290
|
1817698-21-7
|
98%
|
|
BDP5290 is a potent inhibitor of both ROCK and MRCK(IC50s of 5 nM, 50 nM, 10 nM and 100 nM for ROCK1, ROCK2, MRCKα and MRCKβ, respectively.)
|
TQ0110 |
ROCK-IN-2
|
867017-68-3
|
97.59%
|
|
ROCK-IN-2 (Azaindole 1) is a selective and ATP-competitive ROCK inhibitor with IC50 of 0.6 and 1.1 nM for human ROCK-1 and ROCK-2.
|